Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuo Therapeutics, Inc.AURX · Entity 7149 | Director | June 29, 2026 | July 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuo Therapeutics, Inc.
Report date June 29, 2026 · Filed July 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2036-06-29 | Direct | 30,000 |
Reported balance
After 2026-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 30,000 · Balance 30,000 F1: The options fully vest as of June 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The options fully vest as of June 30, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2026 Filed Jul 3, 2026 00:58 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001437749-26-022661 · rdgdoc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-29 F1 · derivative.exercise_date: The options fully vest as of June 30, 2027. Read SEC document |
| December 09, 2025 Filed Dec 12, 2025 02:55 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 9,091 | $2.20 | $20,000.20 |
DisclosureSEC source: 0001437749-25-037614 · rdgdoc.xml · nonDerivative · entry 2 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,294 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock. The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20. Read SEC document |
| December 09, 2025 Filed Dec 12, 2025 02:55 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 50,000 | $0.40 | $20,000.00 |
DisclosureSEC source: 0001437749-25-037614 · rdgdoc.xml · nonDerivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:51 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 9,091 | $2.20 | $20,000.20 |
DisclosureSEC source: 0001437749-25-037591 · rdgdoc.xml · nonDerivative · entry 2 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,294 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock. The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:51 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 50,000 | $0.40 | $20,000.00 |
DisclosureSEC source: 0001437749-25-037591 · rdgdoc.xml · nonDerivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:13 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 20,115 | $1.74 | $35,000.10 |
DisclosureSEC source: 0001437749-25-024499 · rdgdoc.xml · nonDerivative · entry 2 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,385 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 67,385 shares of common stock on the net exercise of option to purchase 87,500 shares of common stock. The issuer withheld 20,115 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:13 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 87,500 | $0.40 | $35,000.00 |
DisclosureSEC source: 0001437749-25-024499 · rdgdoc.xml · nonDerivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2024 Filed Jul 22, 2024 22:50 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 25,000 | $0.33 Strike: $0.33 | $8,250.00 |
DisclosureSEC source: 0001437749-24-023224 · rdgdoc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-07-17 F1 · derivative.exercise_date: Options fully vest on one year anniversary of grant. Read SEC document |
| March 04, 2022 Filed Apr 27, 2022 01:35 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-22-009790 · rdgdoc.xml · derivative · entry 2 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-04 Read SEC document |
| March 04, 2022 Filed Apr 27, 2022 01:35 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 26,666 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001437749-22-009790 · rdgdoc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,666 Underlying: Common Stock · 26,666 shares Expires 2032-03-04 F1 · date: Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:58 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001091596-19-000004 · primary_doc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: COMMON STOCK · 50,000 shares Expires 2025-12-31 Read SEC document |
| December 31, 2018 Filed Dec 12, 2025 02:55 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-037614 · rdgdoc.xml · derivative · entry 3 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Dec 11, 2025 23:51 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 50,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-037591 · rdgdoc.xml · derivative · entry 3 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:18 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 87,500 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001480208-18-000001 · primary_doc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: COMMON STOCK · 87,500 shares Expires 2025-08-08 Read SEC document |
| August 09, 2018 Filed Aug 4, 2025 13:13 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 87,500 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-024499 · rdgdoc.xml · derivative · entry 3 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires 2025-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2017 Filed Jul 10, 2017 12:59 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to purchase Common Stock · Derivative | 18,750 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001480208-17-000004 · primary_doc.xml · derivative · entry 1 Mintz Paul · CIK 0001480208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires 2027-05-10 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.